MyFinsight
Home
Blog
About
Gross Product
$88,464K
(11.01%↑ Y/Y)
Royalty Delivery Of Drug
Supplies And Others
$7,688K
(178.96%↑ Y/Y)
Development Milestones
$4,000K
Product
$67,015K
(13.68%↑ Y/Y)
Contract Revenues From
Collaborations
$11,688K
(-72.65%↓ Y/Y)
Discounts And Allowances
-$21,449K
(-3.40%↓ Y/Y)
Total revenues
$78,703K
(-22.60%↓ Y/Y)
Income from operations
$23,575K
(-61.42%↓ Y/Y)
Interest income
$789K
(4.78%↑ Y/Y)
Total costs and
expenses
$55,128K
(35.84%↑ Y/Y)
Income before income
taxes
$23,585K
(-60.68%↓ Y/Y)
Interest expense and
other
$779K
Selling, general and
administrative
$32,642K
(11.57%↑ Y/Y)
Research and development
$13,961K
(104.68%↑ Y/Y)
Cost of product sales
$8,525K
(89.28%↑ Y/Y)
Net income
$17,290K
(-71.00%↓ Y/Y)
Provision for income taxes
$6,295K
(1605.96%↑ Y/Y)
Back
Back
Income Statement
RIGEL PHARMACEUTICALS INC (RIGL)
RIGEL PHARMACEUTICALS INC (RIGL)
source: myfinsight.com